awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q43551791-E632207A-8B37-4FAE-A96C-6671B6328E2B
Q43551791-E632207A-8B37-4FAE-A96C-6671B6328E2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43551791-E632207A-8B37-4FAE-A96C-6671B6328E2B
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
P2860
Q43551791-E632207A-8B37-4FAE-A96C-6671B6328E2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43551791-E632207A-8B37-4FAE-A96C-6671B6328E2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
327144747e0b8f9aa98a2ba54c9bcab500659b15
P2860
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t